Systemic Uremic Toxin Burden in Autism Spectrum Disorder: A Stratified Urinary Metabolite Analysis.

Researchers measured waste products from gut bacteria in the urine of children with autism compared to typical children. While overall levels were similar, they found different patterns when looking at girls versus boys and children with more severe autism. The balance between different waste products was altered in autism, suggesting changes in gut bacteria activity. This type of testing might help identify gut-related issues in autism better than looking at individual waste products alone.

This study examined urinary concentrations of five gut-derived uremic toxins in 161 children with autism spectrum disorder (ASD) compared to 71 healthy controls. While overall toxin levels were similar between groups, stratified analyses revealed specific patterns: girls with ASD and those with severe autism showed higher p-cresyl sulfate levels, while younger and more severely affected children had reduced indoxyl sulfate and TMAO. Importantly, functional ratios between toxins differed significantly - the IS/PCS ratio declined from 1.69 in controls to 0.99 in severe ASD cases, while PCS/TMAO increased from 12.2 to 20.5. These findings suggest altered gut microbial signatures and host-microbial metabolic balance in ASD, with functional toxin profiling potentially offering more sensitive detection of metabolic disturbances than individual concentration measurements.

Functional toxin profiling may offer more nuanced assessment of gut-brain axis dysfunction in ASD than individual biomarkers. Findings suggest need for stratified approaches considering sex, age, and severity when evaluating metabolic disturbances. Further research needed to establish clinical utility.

Single cross-sectional study design limits causal inferences. Unknown study methodology and lack of detailed demographic matching information. Functional significance of toxin ratio changes unclear. No validation cohort reported.

Autism spectrum disorder (ASD) is increasingly associated with microbial and metabolic disturbances, including the altered production of gut-derived uremic toxins. We investigated urinary concentrations of five representative uremic toxins-indoxyl sulfate (IS), p-cresyl sulfate (PCS), trimethylamine N-oxide (TMAO), asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA)-in 161 children with ASD and 71 healthy controls. Toxins were measured using LC-MS/MS and were normalized to creatinine. Subgroup analyses were performed by sex, age group (2-5.9 vs. 6-17 years), and autism severity based on the Childhood Autism Rating Scale (CARS).

In addition to individual concentrations, we calculated the total toxin burden, proportional contributions, and functional ratios (IS/PCS, PCS/TMAO, and IS/ADMA). While individual toxin levels did not differ significantly between groups, stratified analyses revealed that PCS was higher in girls and in severe cases of ASD, whereas IS and TMAO were reduced in younger and more severely affected children. The functional ratios shifted consistently with severity-IS/PCS declined from 1.69 in controls to 0.99 in severe cases of ASD, while PCS/TMAO increased from 12.2 to 20.5. These patterns suggest a phenolic-dominant microbial signature and an altered host-microbial metabolic balance in ASD.

Functional toxin profiling may offer a more sensitive approach to characterizing metabolic disturbances in ASD than concentration analysis alone.